Why the study?
To investigate the effects of high volume hemofiltration on intracranial pressure, internal environment, cerebral oxygen metabolism, and brain protection in patients with severe craniocerebral injury.
Does high volume hemofiltration improve intracranial pressure and brain metabolism in patients with severe craniocerebral injury?
Does high volume hemofiltration improve intracranial pressure and brain metabolism in patients with severe craniocerebral injury?
High volume hemofiltration added to routine mannitol therapy effectively improves intracranial pressure and brain metabolism in patients with severe craniocerebral injury.
This is the authors' abstract. We don't add key points for this paper.
Objective To investigate the effects of high volume hemofiltration (HVHF) on intracranial pressure, internal environment, cerebral oxygen metabolism and brain protection in patients with severe craniocerebral injury. Methods Totally 114 patients with severe craniocerebral injury were divided into the routine group (57 cases) and HVHF group (57 cases) by the random number table method. The routine group was treated with 0.5 g/kg mannitol intravenously once every 6 hours for 7 days. The HVHF group was treated with HVHF with an ultrafiltration dose of 60 mL·kg-1·h-1 for 72 h on the basis of the routine group. The intracranial pressure, internal jugular venous oxygen saturation (SjvO2), serum Na+ concentration, mean arterial pressure, mechanical ventilation time and hospitalization time of ICU were recorded before and 24 h, 72 h, 7 d after treatment in these two groups. Results There were significant differences in intracranial pressure, serum Na+ and SjvO2 levels between these two groups (F = 8.159, 3.770, 2.787; P < 0.001, = 0.011, 0.040) and there was no significant difference in mean arterial pressure (F = 0.755, P = 0.520). Further pairwise comparison showed that the intracranial pressure in the routine group on 7 days after treatment was significantly lower than that in the same group before treatment (P < 0.05), while the intracranial pressure in the HVHF group decreased significantly at 72 h and 7 d after treatment compared with that in the same group before treatment and at the same time point in the routine group (all P < 0.05). The levels of serum Na+ and SjvO2 at 72 h and 7 d after treatment in the routine group were all significantly higher than those in the same group before treatment (all P < 0.05). The level of serum Na+ in the HVHF group was significantly lower than that in the routine group at 24 h, 72 h and 7 d after treatment (all P < 0.05). The expression of SjvO2 at 72 h and 7 d after treatment was significantly higher than that in the same group before treatment and at the same time point in the routine group (all P < 0.05). There were no significant differences between these two groups in mechanical ventilation time [(13.5 ± 3.3) d vs. (12.5 ± 2.6) d] and hospitalization time of ICU [(18 ± 6) d vs. (16 ± 5) d] (t = 1.797, 1.599; P = 0.075, 0.113). Conclusion HVHF can effectively improve intracranial pressure and brain metabolism in patients with severe craniocerebral injury, which can protect the brain and stabilize the internal environment.
Answers are grounded in this paper and cite their sources.
HVHF adjunct to mannitol may lower ICP and improve cerebral metabolism in severe TBI; extends sparse RCT data on CRRT for neuroprotection.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: